BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16390238)

  • 1. Warthin tumors do not have microsatellite instability and express normal DNA mismatch repair proteins.
    Hunt JL
    Arch Pathol Lab Med; 2006 Jan; 130(1):52-6. PubMed ID: 16390238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
    Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
    Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma.
    Rosen DG; Cai KQ; Luthra R; Liu J
    Mod Pathol; 2006 Nov; 19(11):1414-20. PubMed ID: 16941012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors.
    Castrilli G; Fabiano A; La Torre G; Marigo L; Piantelli C; Perfetti G; Ranelletti FO; Piantelli M
    J Oral Pathol Med; 2002 Apr; 31(4):234-8. PubMed ID: 12076327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.
    Cai KQ; Albarracin C; Rosen D; Zhong R; Zheng W; Luthra R; Broaddus R; Liu J
    Hum Pathol; 2004 May; 35(5):552-9. PubMed ID: 15138928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability in esophageal adenocarcinoma.
    Evans SC; Gillis A; Geldenhuys L; Vaninetti NM; Malatjalian DA; Porter GA; Guernsey DL; Casson AG
    Cancer Lett; 2004 Aug; 212(2):241-51. PubMed ID: 15279904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
    Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
    Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.
    Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA
    Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours.
    Devouassoux-Shisheboran M; Mauduit C; Bouvier R; Berger F; Bouras M; Droz JP; Benahmed M
    Mol Hum Reprod; 2001 Dec; 7(12):1099-105. PubMed ID: 11719586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
    Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
    Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
    Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
    J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
    Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
    Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.
    Shin KH; Park JG
    Eur J Cancer; 2000 May; 36(7):925-31. PubMed ID: 10785599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin of microsatellite instability in gastric cancer.
    Halling KC; Harper J; Moskaluk CA; Thibodeau SN; Petroni GR; Yustein AS; Tosi P; Minacci C; Roviello F; Piva P; Hamilton SR; Jackson CE; Powell SM
    Am J Pathol; 1999 Jul; 155(1):205-11. PubMed ID: 10393852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
    Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
    Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
    Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
    Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.
    Rigau V; Sebbagh N; Olschwang S; Paraf F; Mourra N; Parc Y; Flejou JF
    Arch Pathol Lab Med; 2003 Jun; 127(6):694-700. PubMed ID: 12741892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.
    Chai SM; Zeps N; Shearwood AM; Grieu F; Charles A; Harvey J; Goldblatt J; Joseph D; Iacopetta B
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1017-25. PubMed ID: 15551255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.